Navigation Links
BioMed Realty Trust Reports Third Quarter 2010 Financial Results
Date:11/3/2010

including the impact of the assumed conversion of the company's exchangeable senior notes due 2030.2011(Low - High)Projected net income per diluted share availableto common stockholders

$0.35– $0.45  Add:Noncontrolling interests in operating partnership

$0.01Real estate depreciation and amortization

$0.83  Less:Assumed conversion of senior exchangeable notes due 2030

($0.04)Projected FFO per diluted share

$1.15 – $1.25At the mid-point, the company's 2011 FFO guidance represents a 7.1% increase over the annualized results for the third quarter of 2010.

The 2011 guidance includes the following assumptions:

  • Leasing and Portfolio Activity
  • The company anticipates new and renewal leasing transactions totaling approximately 1,200,000 square feet over the five quarters extending from October 1, 2010 through December 31, 2011, including early renewals and extensions of approximately 150,000 square feet related to leases which are currently scheduled to expire after December 31, 2011. The company currently has 610,000 square feet of scheduled expirations, including month-to-month leases, over the five quarters extending from October 1, 2010 through December 31, 2011, resulting in an estimated positive net absorption of approximately 450,000 square feet.
  • As a result, the company expects the current operating portfolio to achieve stabilization 90.0%+ by December 31, 2011.  
  • Investment Activity
  • Unidentified future acquisitions totaling approximately $150 million, occurring ratably over the year.
  • Approximately $58 million to complete the Gazelle Court development, which is 100% leased to Isis Pharmaceuticals, Inc.
  • Approximately $50 to $75 million of leasing related capital investment, including tenant improvement allowances and leasing commissions, subject to leasing activity.
  • No new development starts.
  • Financing Activity
  • Exercise of t
    '/>"/>

  • SOURCE BioMed Realty Trust, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related biology technology :

    1. Reportlinker Adds Next Generation U.S. and E.U. Biomaterials/BioMedical Devices: Market Trends & Commercial Implications
    2. BioMed Realty Trust Completes South San Francisco Portfolio Acquisition
    3. BioMed Realty Trust to Report 2010 Third Quarter Results
    4. BioSpace and BioMed Central Create Global Career Community
    5. DSM Biomedical Announces Continued Partnership with Spinelab
    6. BioMed Realty Trust Declares Second Quarter 2010 Common Stock and Preferred Stock Dividends
    7. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
    8. BioMed Realty Trust Promotes Greg Lubushkin to Chief Financial Officer
    9. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
    10. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
    11. BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... 1000 balances – 4 steps – One Recommendation: the ... expertly narrows down the mass of product choices to ... , First, select the working environment, then enter ... and define the accuracy – it’s really that simple. ... list to models that fit best with the customer’s ...
    (Date:7/24/2014)... The first part of the session ... in Human Studies” will cover comprehensive clinical support in ... With increasing R&D costs and declining industry success in ... the knowledge collected in early Phase I/IIa study data ... late stage development. , Next, the presenters will examine ...
    (Date:7/24/2014)... Francisco, CA (PRWEB) July 24, 2014 ... http://www.draperuniversity.com , is proud to announce that ... from 17 different countries will converge on the ... Valley for an intensive, experiential program focused on ... The highly selective school, currently running its sixth ...
    (Date:7/24/2014)... July 24, 2014  Spherix Incorporated (SPEX) -- an ... monetization of intellectual property, today announced that the Company ... June 30, 2014 on Monday, August 18, 2014 for ... a.m. ET on Monday, August 18, 2014 to discuss ... the company,s CEO, Anthony Hayes . ...
    Breaking Biology Technology:Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Spherix Schedules Shareholder Update Call 2
    ... Entomologists at the University of California, Riverside working on ... of compounds that could pave the way for developing inexpensive ... other deadly tropical diseases. When fruit flies undergo stress, ... a warning to other fruit flies that danger or predators ...
    ... HARBIN, China, Aug. 26 ... One Medical" or "the Company") (Nasdaq: ... over-the-counter,drugs in the People,s Republic of China ("PRC"), ... been raised with respect to financial reports filed,with ...
    ... , PARIS, August 26 , - Net Profit Up 11%, - Strong Research ... The Board of Directors, meeting on 25 August 2009 under the chairmanship,of Albert Saporta approved the 2009 half year financial ... 08/07 H1 2009, ... Var.% %CA, Sales ...
    Cached Biology Technology:Discovery of natural odors could help develop mosquito repellents 2Discovery of natural odors could help develop mosquito repellents 3China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports 2China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports 3STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 2STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 3STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 4
    (Date:7/24/2014)... a virus living inside your gut that has gone ... by researchers at San Diego State University has found ... to a newly described virus, named crAssphage, which infects ... Bacteroidetes . This phylum of bacteria is thought ... diseases. The research appears today in Nature Communications ...
    (Date:7/23/2014)... DIEGO , July 24, 2014 Pfenex Inc. ... public offering of 8,333,333 shares of its common stock at ... addition, Pfenex has granted the underwriters a 30-day option to ... the initial public offering price. The shares are expected to ... under the symbol "PFNX". William Blair ...
    (Date:7/23/2014)... A new study of identical twins has found that ... The study, in the journal Child Development , ... and King,s College London. , "Since reading is an ... for reading instruction," according to Stuart J. Ritchie, research ... led the study. "Early remediation of reading problems might ...
    Breaking Biology News(10 mins):Newly discovered gut virus lives in half the world's population 2Newly discovered gut virus lives in half the world's population 3Pfenex Inc. Announces Pricing Of Initial Public Offering 2Stronger early reading skills predict higher intelligence later 2
    ... in extreme cold, scientists no longer have to go ... Bacteria previously isolated from polar climates, and have properties ... been isolated from soil in temperate environments. , Professor ... have developed a technique to isolate bacteria which have ...
    ... the four bacterial surface proteins that generate the ... University of Chicago have created a vaccine that ... strains of Staphylococcus aureus, the most common cause ... of community-associated illness. , The vaccine protected ...
    ... The repeated copying of a small segment of DNA in ... to the transition of ancient animals from sea to land, ... discovery is "tantalizing evidence" that copied DNA elements known as ... the director of the research, Howard Hughes Medical Institute investigator ...
    Cached Biology News:MRSA vaccine shows promise in mouse study 2MRSA vaccine shows promise in mouse study 3Mobile DNA part of evolution's toolbox 2Mobile DNA part of evolution's toolbox 3Mobile DNA part of evolution's toolbox 4
    Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
    Each 72-well MiniTray is low profile, with lid. Conical well shape, 10 l....
    The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
    ...
    Biology Products: